Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Scope of the Report:
North America region is the largest supplier of Spine Biologics, with a production market share nearly 63%. Europe is the second largest supplier of Spine Biologics, enjoying production market share nearly 28%.
North America is the largest consumption place, with a consumption market share nearly 61%. Following North America, Europe is the second largest consumption place with the consumption market share of 21%.
Market competition is not intense. Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive and Zimmer Biomet etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. The Market Share of Medtronic is 40% in 2015.
With the developm ...
Table of Contents
1 Market Overview
1.1 Spine Biologics Introduction
1.2 Market Analysis by Type
1.2.1 Bone Graft
1.2.2 Bone Graft Substitute
1.2.3 Platelet Rich Plasma (PRP)
1.2.4 BMAC (Bone Marrow Aspirate Concentrate)
1.3 Market Analysis by Applications
1.3.1 Anterior Cervical Discectomy and Fusion
1.3.2 Posterior Lumbar Interbody Fusion
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
188.8.131.52 United States Market States and Outlook (2014-2024)
184.108.40.206 Canada Market States and Outlook (2014-2024)
220.127.116.11 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
18.104.22.168 Germany Market States and Outlook (2014-2024)
22.214.171.124 France Market States and Outlook (2014-2024)
126.96.36.199 UK Market States and Outlook (2014-2024)
188.8.131.52 Rus ...